Approvals/TGA/BIVALIRUDIN JUNO bivalirudin (as trifluoroacetate) 250mg Powder for Injection vial

Approved

STANDARD

BIVALIRUDIN JUNO bivalirudin (as trifluoroacetate) 250mg Powder for Injection vial

Juno Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 0fa3b0a997d904f4
Product Name: BIVALIRUDIN JUNO bivalirudin (as trifluoroacetate) 250mg Powder for Injection vial
Artg Id: 226748
Artg Name: BIVALIRUDIN JUNO bivalirudin (as trifluoroacetate) 250mg Powder for Injection vial
Sponsor: Juno Pharmaceuticals Pty Ltd
Company Detail Path: /organization/juno-pharmaceuticals-pty-ltd
Artg Date: 2015-07-24
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

0fa3b0a997d904f4

Type

Standard